LOS
ANGELES, May 6, 2024 /PRNewswire/ -- Golden
Globe nominee Jennifer Grey, Chief
Strategy & Marketing Officer for GE HealthCare Andy DeLaO, and
Director of the Tumor Immunology Program at UCLA's Jonsson Comprehensive Cancer Center,
physician-scientist Antoni Ribas,
MD, PhD, will be honored for their commitment to raising awareness
about cancer, and ending the disease, at Tower Cancer Research
Foundation's (Tower Cancer's) 22nd Annual Tower of
Hope Gala in Beverly Hills on Tuesday evening, May 7th, 2024. Leaders in entertainment,
politics, business, medicine and philanthropy will join to
celebrate the honorees as well as mark
the integration earlier this year of the work and assets
of Dr. Susan Love (1948-2023),
founder and Chief Visionary Officer of the Dr. Susan Love
Foundation for Breast Cancer Research, into Tower Cancer. The
event begins at 6:00 PM at the
Beverly Wilshire, A Four Seasons Hotel, 9500 Wilshire Boulevard in
Beverly Hills, California.
Jennifer Grey is best known
for her iconic portrayal as 'Baby' in the beloved film classic
"Dirty Dancing," which garnered her a Golden Globe nomination for
Best Actress, as well as her breakout role as Matthew Broderick's sister in John Hughes' "Ferris
Bueller's Day Off." Currently, Grey can be seen
starring in Jesse Eisenberg's
feature film "A Real Pain," which premiered at this year's Sundance
Film Festival and was acquired by Searchlight Pictures. With
a host of TV and film credits, Grey is also a bestselling author
whose memoir, "Out of the Corner," became an instant New York Times bestseller in 2022. She most
recently wrapped production on Julia
Stiles' directorial debut for Lionsgate, "Wish You Were
Here," opposite Kelsey
Grammer. Grey will be honored with Tower Cancer's
Ambassador of the Year Award.
"A cancer diagnosis has a knack for instantly shattering the
illusion of immortality along with our plans, dreams, schemes, and
with that, can transform the quality of our lives, as seen through
a different lens, bringing all of what truly matters most into
focus, with a newfound appreciation for how fleeting and fragile
this life is," noted Ms. Grey, herself a thyroid cancer
survivor. "I'm one of the lucky ones, but I believe that we
need to have answers for those whose cancer returns, or who are
diagnosed at a late stage, which is why I believe Tower Cancer
Research Foundation is such a valuable resource and does incredibly
important work. Tower Cancer's contribution to groundbreaking
research, their commitment to patient support programs and their
emphasis on launching the next generation of scientists gives us
all hope that our collective future can be free of cancer."
Andy DeLaO will be honored
with Tower Cancer's Dr. Love Visionary Award. DeLaO is the Chief
Strategy & Marketing Officer for GE Healthcare's business
focused on building care at the n-of-1 using the diagnostic gateway
to precision health and care. He has a clinical background in
radiation oncology and physics. DeLaO has led teams to design and
run 25 cancer centers and 150 risk reduction facilities globally.
He sits on the Board of Directors for Avant Diagnostics, and also
on the American College of Radiology's Patient and Family Centered
Care Committee.
Antoni Ribas, MD, PhD, is
professor of medicine, surgery, and molecular and medical
pharmacology at the University of California
Los Angeles, and director of the Tumor Immunology Program at
the Jonsson Comprehensive Cancer Center. Ribas is a
physician-scientist conducting laboratory and clinical
translational research into how melanoma responds or persists to
cancer immunotherapies, and developing gene engineered adoptive
cell transfer therapies. He has been instrumental in the
clinical development of several FDA-approved agents, including the
first anti-PD-1 pembrolizumab (Keytruda), the anti-CTLA-4
tremelimumab (Imjudo), as well as two combinations of BRAF and MEK
inhibitors, vemurafenib (Zelboraf) and cobimetinib (Cotellic), and
dabrafenib (Tafinlar) and trametinib (Mekinist). He is
affiliated with multiple international cancer research
associations, and is a past president of the American Association
for Cancer Research. Ribas will be honored with Tower
Cancer's Healing Award.
Through local investments, Tower Cancer advances groundbreaking
cancer research and profoundly supports people affected by the
disease to create outsized impact in Southern California, and beyond.
Gala tickets may be purchased here or by calling
310-299-8470.
MEDIA CREDENTIALING: ALL MEDIA MUST BE
PRE-REGISTERED AND APPROVED FOR A CREDENTIAL.
Click here for Media RSVP and Talent Inquiries.
ABOUT TOWER CANCER RESEARCH FOUNDATION (TOWER
CANCER): Tower Cancer Research Foundation was
founded over 25 years ago, with the goal of
independently advancing groundbreaking research and
profoundly supporting people affected by cancer — as we inch
closer to a future free from the burden of this devastating
disease. Inspired by the most promising science, we fund
leading local researchers, making us a launchpad for
additional funding and discoveries here and on the global stage.
Our clinically-grounded patient support programs, hosted by
Magnolia House, and community
partner grants, funded by Tower Cancer, align with the challenges
faced by patients, survivors, and the whole cancer community. We
believe that impact begins here, and it starts with you.
www.towercancer.org
Contact: Rachel Schwartz/PR
AdvantEDGE
Inc.
310.990.2764
377289@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/jennifer-grey-to-be-honored-for-her-cancer-advocacy-along-with-chief-strategy--marketing-officer-for-ge-healthcare-andy-delao-and-renowned-cancer-physician-scientist-dr-antoni-ribas-at-tower-cancer-research-foundations-22nd-an-302136712.html
SOURCE Tower Cancer Research Foundation